Fresenius Medical Care AG & Co. KGaA

NYSE:FMS

Medical - Care Facilities

Healthcare
$20.95 -0.76%

-$0.18 today

Market cap
$11.26B
Beta
0.81
P/E (TTM)
11.9
EPS (TTM)
$3.43
Dividend yield
3.65%
52W Low $20.02High $28.87

Volume 1.92M

Average 0.72M

FMS Income Before Tax

Profit after all operating and non-operating items but before income tax.

Fresenius Medical Care AG & Co. KGaANYSE: FMS

Income Before Tax · Q2 FY2026 · quarter ended Jun 2026

Income before tax grows, but more slowly than its trailing trend

Q2 FY2026 income before tax of €383M rose 9.3% year over year, behind the +29.3% change in trailing-twelve-month income before tax. Sequentially, it rose 84.6% from the prior quarter. Over 3 fiscal years it compounded at +7.4% a year.

Context

  • Income before tax amounted to 7.7% of revenue in FY2025, up 2.2 pp from a year earlier.
  • Income before tax increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +9.3% toward the trailing-twelve-month pace of +29.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
€383M+84.6% QoQ
Last fiscal yearDec 2025
€1.51B+43.1% YoY
LTMJun 2026
€1.5B+29.3% YoY
Income Before Tax past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+9.3%——
1 year+43.1%——
3-year CAGR+7.4%——
5-year CAGR——
10-year CAGR——

Income Before Tax history

EUR · from the income statement

Latest · FY2025
1.51B EUR
Year-over-year change
+43.1%
4-year CAGR
-1.0%

Income Before Tax vs competitors

How FMS compares with its peers on the latest reported figures

  • Peers report in different currencies, so income before tax is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +29.3% is the 2nd highest of 4, against a peer median of +1.8%.
  • Income before tax amounts to 7.7% of revenue for FMS, versus a peer median of 10.5%.
FMS Competitors
Income Before Tax for FMS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
FMSFresenius Medical Care AG & Co. KGaALTM Jun 2026€1.5B EUR+29.3%+7.4%7.7%
DVADaVita Inc.LTM Jun 2026$1.47B USD+1.8%+11.7%10.5%
AKBAAkebia Therapeutics, Inc.LTM Mar 2026-$18.76M USD+58.6%—8.1%
TVTXTravere Therapeutics, Inc.LTM Sep 2026-$159.72M USD-80.4%—24.5%
Peer median (excluding FMS) —+1.8%+11.7%10.5%

Competitors are the stored peer set for FMS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue17.62B19.4B19.45B19.34B19.63B
Cost of Revenue12.85B14.5B14.53B14.58B14.6B
Gross Profit4.77B4.89B4.93B4.76B5.03B
Gross Margin27.1%25.2%25.3%24.6%25.6%
Research & Development220.78M228.62M231.97M183.49M157.98M
Selling, General & Admin2.77B3.17B3.2B3.14B3.03B
Operating Expenses2.92B3.38B3.56B3.29B3.2B
Depreciation & Amortization1.62B1.84B1.75B1.74B1.5B
EBITDA3.55B3.42B3.21B3.21B3.4B
EBITDA Margin20.1%17.6%16.5%16.6%17.3%
Operating Income1.85B1.51B1.37B1.47B1.83B
Operating Margin10.5%7.8%7.0%7.6%9.3%
Interest Income73.17M67.66M88.22M71.58M69.61M
Interest Expense353.6M360.14M424.64M407.04M384.41M
Other Income / Expenses(280.43M)(292.48M)(336.42M)(410.45M)(314.59M)
Income Before Tax1.57B1.22B1.03B1.06B1.51B
Pre-Tax Margin8.9%6.3%5.3%5.5%7.7%
Income Tax Expense352.83M324.95M300.56M316.06M320.97M
Net Income969.31M673.41M499M537.91M978.37M
Net Margin5.5%3.5%2.6%2.8%5.0%
EPS (Basic)0.830.570.850.921.68
EPS (Diluted)0.830.570.850.921.68
Weighted Avg Shares1.17B1.17B586.83M586.83M582.38M
Weighted Avg Shares (Diluted)1.17B1.17B586.83M586.83M582.38M

Fresenius Medical Care AG & Co. KGaA

NYSE:FMS

Intrinsic Alpha fair value

Locked

Current Price

$20.95

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.